降糖药吡格列酮合成方法的比较与评价(3)
 |
| 第1页 |
参见附件(2475KB，4页)。
[8] Halama A, Hejtntankova L, Lustig IP, et al. Preparation of pioglitazone from aminophenols and leaving-group substituted alkylpyridines [P]. WO: 02088120,2002-11-07.
[9]Rajendra GL, Parag NG, Maya JS, et al. Improved process for preparation of thiazolidinedione derivatives [P]. WO:2004024059A2, 2004-03-25.
[10]胡祖耀,郑直.5-[4-[2-(5-乙基-2-吡啶基)乙氧基]苯亚甲基]-2,4-噻唑烷二酮的制备方法[P].CN:1459450,2003-12-03.
[11]王法平, 李晓翔.5-[4-2-(5-乙基-2-吡啶基)乙氧基]苯基甲基]-2,4-噻唑烷二酮的制备方法[P].CN:1603323,2005-04-06.
[12]Adiyaman M, Guner D, Yurdakul A, et al. A process for the production of 5-[4-[2-(5-etheyl-2-pyridylethoxy)benzyl]-2,4-thiazolidinedione]hydro chloride [P]. WO: 2004000810,2003-12-31.
[13]Meguro K, Fujita T, Hatanaka C, et al. A method for producing thiazo-lidinedione derivatives as antidiabetics and antihyperlipidemics [P]. EP:257781,1988-03-02.
[14]Huber JE. Regioselective reduction of substituted 5-(methylene) thiazo-lidinediones [P]. WO:9313095,1993-07-08.
[15]Momose Y, Meguro K, Ikeda H, et al. Synthesis and biological activi-ties of pioglitazone and related compounds [J]. Chem Pharm Bull,1991,39(6):1440-1445.
[16]Clark DA, Goldstein SW, Volkmann RA, et al. Substituted dihydrobenzo-pyran and dihydrobenzo furan thiazolidine-2,4-diones as hypoglycemic agents [J]. J Med Chem,1991,(34):319-325.
[17]Pandey B, Lohray VB, Lohray BB. A novel process to prepare piogli-tazone via several novel intermediates [P]. WO:2004007490,2004-01-22 ......
您现在查看是摘要介绍页，详见PDF附件(2475KB，4页)。